No Data
No Data
Chimin Health Management (SHSE:603222) Adds CN¥381m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 81%
Ji'min Health (603222.SH): The hospital fully enjoys the preferential policies for the related industries given by the state to the Boao Lecheng International Medical Tourism Pilot Zone.
GeLongHui September 6th | JiMin Health (603222.SH) stated on the interactive platform that its Baoao International Hospital is located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, the first hospital to enter the zone. The hospital fully enjoys the related industrial preferential policies given by the country to the Boao Lecheng International Medical Tourism Pilot Zone. The 'Notice on the Zero Tariff Policy for Pharmaceutical and Medical Device in Hainan Free Trade Port' stipulates that medical institutions, medical education institutions, and pharmaceutical institutions registered and recognized with independent legal personality in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan will be exempt from tariffs.
Jimin Health Management Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Jimin Health Management Co., Ltd.
JiMin Health (603222.SH): net income for the first half of the year was 25.445 million yuan, a 35.14% year-on-year decline.
Gelonghui August 28th 丨 JIMIN Health (603222.SH) released its semi-annual report, during the reporting period, the company achieved a total operating income of 465.6441 million yuan, a 4.79% increase compared to the same period last year; the net income attributable to shareholders of the listed company was 25.445 million yuan, a 35.14% decrease compared to the same period last year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 24.4007 million yuan, a 33.90% decrease compared to the same period last year; the net cash flow from operating activities was 41.728 million yuan, a 34.2% decrease compared to the same period last year. The company is attributable to the shareholders of the listed company
Ji Min Health (603222.SH) announced its performance for the first half of the year, with a net income of 25.445 million yuan, a decrease of 35.14%.
JiMin Health (603222.SH) released its 2024 interim report. During the reporting period, the company achieved revenue...
No Data
No Data